Fluconazol Vitabalans (Fluconazole 150 mg)
Triazole antifungal tablet for the treatment of Candida and other fungal infections
Quick Facts about Fluconazol Vitabalans
Key Takeaways about Fluconazol Vitabalans
- Effective against Candida: Fluconazole is the first-line treatment for most forms of candidiasis, including vaginal, oropharyngeal, and systemic infections
- Convenient dosing: The long half-life (~30 hours) allows once-daily dosing, and a single 150 mg dose is often sufficient for uncomplicated vaginal candidiasis
- Drug interactions: Fluconazole is a potent CYP450 inhibitor and can significantly increase levels of warfarin, phenytoin, cyclosporine, and many other medications
- Pregnancy caution: Fluconazole should be avoided during pregnancy, especially at high doses or with prolonged use, due to potential teratogenic effects
- Liver monitoring: Hepatotoxicity can occur; liver function should be monitored during prolonged treatment, and the drug should be discontinued if signs of liver damage develop
What Is Fluconazol Vitabalans and What Is It Used For?
Fluconazol Vitabalans is an antifungal medicine containing fluconazole 150 mg as its active substance. It belongs to the triazole class of antifungal agents and is used to treat and prevent infections caused by Candida species and other susceptible fungi, including Cryptococcus neoformans.
Fluconazole was first developed by Pfizer and approved for medical use in 1990. Since then, it has become one of the most important antifungal agents in clinical medicine, recognized for its broad-spectrum activity against many fungal pathogens, excellent oral bioavailability (over 90%), and favorable safety profile. The World Health Organization (WHO) includes fluconazole on its Model List of Essential Medicines, reflecting its critical role in global healthcare.
Fluconazol Vitabalans is a generic formulation manufactured by Vitabalans Oy. It contains the same active substance as the original branded product and meets the same quality, safety, and efficacy standards required by regulatory authorities. The 150 mg tablet strength is the most commonly prescribed dose for acute, uncomplicated fungal infections.
Fluconazole works by inhibiting a key fungal enzyme called lanosterol 14-alpha-demethylase (CYP51), which is part of the cytochrome P450 system in fungi. This enzyme is essential for converting lanosterol into ergosterol, a vital component of the fungal cell membrane. Without adequate ergosterol, the fungal cell membrane becomes unstable and permeable, ultimately leading to fungal cell death. Importantly, fluconazole is much more selective for the fungal enzyme than for human cytochrome P450 enzymes, which contributes to its relatively good safety profile in humans.
Approved Indications
Fluconazol Vitabalans is indicated for the treatment and/or prophylaxis of the following fungal infections:
- Vaginal candidiasis (vaginal thrush): Acute and recurrent vulvovaginal candidiasis. A single 150 mg oral dose is the standard treatment for uncomplicated cases.
- Oropharyngeal candidiasis (oral thrush): Infection of the mouth and throat mucosa, commonly seen in immunocompromised patients, including those with HIV/AIDS.
- Esophageal candidiasis: Candida infection of the esophagus, a common opportunistic infection in patients with advanced HIV disease.
- Systemic candidiasis: Including candidemia (Candida in the bloodstream), disseminated candidiasis, and peritonitis caused by Candida species.
- Cryptococcal infections: Including cryptococcal meningitis, a life-threatening infection particularly common in HIV-positive patients. Fluconazole is used both for acute treatment (in combination with other agents) and long-term suppressive therapy.
- Dermatophytosis: Fungal skin infections including tinea pedis (athlete's foot), tinea corporis (ringworm), tinea cruris (jock itch), and onychomycosis (nail fungal infection).
- Prophylaxis: Prevention of fungal infections in immunocompromised patients, including those undergoing bone marrow transplantation, receiving chemotherapy, or with prolonged neutropenia.
Fluconazole is included on the WHO Model List of Essential Medicines (2023 edition) as an essential antifungal agent. It is recommended by the WHO, IDSA (Infectious Diseases Society of America), and ESCMID (European Society of Clinical Microbiology and Infectious Diseases) as first-line therapy for many forms of candidiasis.
What Should You Know Before Taking Fluconazol Vitabalans?
Before taking Fluconazol Vitabalans, inform your doctor about all other medications you take, any liver or kidney problems, heart rhythm disorders, and whether you are pregnant, planning pregnancy, or breastfeeding. Fluconazole has important contraindications and drug interactions that must be evaluated.
Fluconazole is generally well tolerated, but like all medicines, it is not suitable for everyone. Your healthcare provider needs a complete picture of your medical history and current medications to ensure safe use. Certain conditions and concurrent medications make fluconazole use either contraindicated or require special monitoring and dose adjustments.
Contraindications
Fluconazol Vitabalans must not be used in the following situations:
- Hypersensitivity: Known allergy to fluconazole, other azole antifungal agents, or any of the excipients in the tablet formulation.
- Co-administration with terfenadine: In patients receiving fluconazole at doses of 400 mg/day or higher, concurrent use of terfenadine is contraindicated due to the risk of serious cardiac arrhythmias (QT prolongation and torsades de pointes).
- Co-administration with cisapride: Fluconazole significantly increases cisapride plasma levels, which can lead to QT prolongation and life-threatening ventricular arrhythmias.
- Co-administration with pimozide: Concurrent use is contraindicated due to the risk of QT prolongation.
- Co-administration with erythromycin: When used with fluconazole, erythromycin may cause QT prolongation and cardiac arrhythmias.
Warnings and Precautions
Special care is needed in the following situations:
- Hepatotoxicity: Fluconazole has been associated with rare but serious cases of liver toxicity, including hepatitis, cholestasis, and fulminant hepatic failure, some resulting in death. The risk appears higher in patients with serious underlying medical conditions. If signs or symptoms of liver disease develop (persistent nausea, vomiting, abdominal pain, fatigue, anorexia, jaundice, dark urine), fluconazole should be discontinued immediately.
- QT prolongation: Fluconazole has been associated with prolongation of the QT interval on electrocardiogram (ECG). Use with caution in patients with pre-existing cardiac disease, electrolyte imbalances (hypokalemia, hypomagnesemia), or those taking other medications known to prolong the QT interval.
- Skin reactions: Rare cases of serious exfoliative skin reactions, including Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), have been reported. If a patient develops a rash that could be attributed to fluconazole, the drug should be discontinued.
- Adrenal insufficiency: Azole antifungals, including fluconazole, have been associated with adrenal insufficiency, particularly at high doses or with prolonged use. Monitor patients for signs and symptoms.
- Renal impairment: Fluconazole is primarily excreted by the kidneys. Dose reduction is required in patients with impaired renal function (creatinine clearance below 50 mL/min).
Pregnancy and Breastfeeding
Fluconazole use during pregnancy requires careful consideration:
- Pregnancy: Fluconazole is contraindicated during pregnancy for most indications, particularly at high doses (400-800 mg/day) or with prolonged use. Case reports and epidemiological studies have identified a pattern of birth defects (including craniofacial, skeletal, and cardiac abnormalities) associated with high-dose fluconazole exposure during the first trimester. A single low dose (150 mg) for vaginal candidiasis has not been conclusively linked to increased teratogenic risk in large population studies, but topical antifungal treatments are preferred during pregnancy. Women of childbearing potential should use effective contraception during and for at least one week after fluconazole treatment.
- Breastfeeding: Fluconazole is excreted in breast milk at concentrations similar to plasma levels. A single 150 mg dose is generally considered compatible with breastfeeding by many expert guidelines (including the American Academy of Pediatrics), but prolonged or high-dose therapy requires individual risk-benefit assessment. Consult your healthcare provider.
Do not use fluconazole during pregnancy unless specifically prescribed by your doctor for a serious or life-threatening fungal infection where the benefits clearly outweigh the risks. If you discover you are pregnant while taking fluconazole, stop the medication and contact your healthcare provider immediately.
How Does Fluconazol Vitabalans Interact with Other Drugs?
Fluconazole is a potent inhibitor of the cytochrome P450 enzymes CYP2C9 and CYP3A4, and a moderate inhibitor of CYP2C19. This means it can significantly increase blood levels of many commonly used medications, potentially leading to toxicity. Always inform your doctor of all medicines you are taking.
Drug interactions are one of the most clinically important considerations when prescribing fluconazole. Because it inhibits key liver enzymes responsible for metabolizing many medications, fluconazole can cause unexpected increases in the blood levels of those drugs. Similarly, some medications can affect fluconazole's own blood levels, either increasing the risk of side effects or reducing antifungal efficacy.
The table below summarizes the most clinically significant drug interactions with fluconazole. This is not an exhaustive list; always consult your pharmacist or prescribing physician for a complete interaction check before starting fluconazole.
Major Interactions (Contraindicated or Avoid)
| Drug | Effect | Clinical Significance |
|---|---|---|
| Terfenadine | Increased terfenadine levels | Contraindicated. Risk of fatal cardiac arrhythmias (torsades de pointes) |
| Cisapride | Increased cisapride levels | Contraindicated. Risk of QT prolongation and ventricular arrhythmias |
| Pimozide | Increased pimozide levels | Contraindicated. Risk of QT prolongation |
| Erythromycin | Additive QT prolongation | Contraindicated. Risk of cardiac arrhythmias |
| Warfarin | Markedly increased warfarin effect (CYP2C9 inhibition) | Monitor INR closely. Dose reduction of warfarin often needed. Risk of serious bleeding |
Significant Interactions (Use with Caution)
| Drug | Effect | Management |
|---|---|---|
| Phenytoin | Increased phenytoin levels | Monitor phenytoin levels and adjust dose. Risk of phenytoin toxicity |
| Cyclosporine | Increased cyclosporine levels | Monitor cyclosporine levels closely. Dose reduction may be necessary |
| Tacrolimus | Increased tacrolimus levels | Monitor tacrolimus levels. Risk of nephrotoxicity |
| Rifampicin | Decreased fluconazole levels (CYP induction) | Consider increasing fluconazole dose. Monitor antifungal efficacy |
| Midazolam / Triazolam | Increased benzodiazepine levels (CYP3A4 inhibition) | Reduce benzodiazepine dose. Monitor for excessive sedation |
| Statins (simvastatin, atorvastatin) | Increased statin levels | Increased risk of rhabdomyolysis. Consider statin dose reduction or temporary discontinuation |
| Sulfonylureas (glipizide, glyburide) | Increased sulfonylurea levels | Monitor blood glucose. Risk of hypoglycemia |
| Oral contraceptives | May increase ethinyl estradiol and levonorgestrel levels | Clinical significance uncertain with single doses. Monitor for estrogenic side effects with prolonged use |
This list does not include all possible interactions. Before starting Fluconazol Vitabalans, give your doctor and pharmacist a complete list of all prescription medicines, over-the-counter products, vitamins, and herbal supplements you are taking. Do not start, stop, or change the dose of any medicine without your doctor's approval.
What Is the Correct Dosage of Fluconazol Vitabalans?
The dosage of Fluconazol Vitabalans depends on the type and severity of the fungal infection. For uncomplicated vaginal candidiasis, a single 150 mg dose is usually sufficient. For other infections, the dose ranges from 50-400 mg daily, with treatment duration varying from a few days to several months. Your doctor will determine the appropriate dose for your condition.
Fluconazole dosing is individualized based on the type of infection, its severity, the patient's renal function, and the specific fungal pathogen involved. The following dosage guidelines are based on recommendations from the EMA Summary of Product Characteristics, FDA prescribing information, and IDSA clinical practice guidelines. Always follow your doctor's specific instructions.
Adults
| Indication | Dose | Duration |
|---|---|---|
| Vaginal candidiasis | 150 mg single dose | One dose |
| Recurrent vaginal candidiasis | 150 mg every 72 hours x 3, then 150 mg weekly | 6 months maintenance |
| Oropharyngeal candidiasis | 200 mg day 1, then 100 mg daily | 7-14 days |
| Esophageal candidiasis | 200 mg day 1, then 100-200 mg daily | 14-30 days |
| Systemic candidiasis | 400 mg day 1, then 200-400 mg daily | Minimum 2 weeks after blood cultures negative |
| Cryptococcal meningitis | 400 mg day 1, then 200-400 mg daily | 10-12 weeks (consolidation), then 200 mg daily maintenance |
| Dermatophytosis | 150 mg once weekly or 50 mg daily | 2-6 weeks depending on site |
Children
Fluconazole is approved for use in children from birth. Dosing in children is based on body weight, with a maximum dose generally not exceeding adult dosing. The pharmacokinetics of fluconazole differ in neonates, with a longer half-life requiring less frequent dosing in the first two weeks of life.
Pediatric Dosing Principles
- Oropharyngeal candidiasis: 3 mg/kg on day 1, then 3 mg/kg daily for at least 2 weeks
- Systemic candidiasis / cryptococcal infections: 6-12 mg/kg daily depending on severity
- Prophylaxis in immunocompromised: 3-12 mg/kg daily based on degree and duration of neutropenia
- Neonates (0-2 weeks): Same mg/kg dose but administered every 72 hours due to prolonged half-life
- Neonates (2-4 weeks): Same mg/kg dose administered every 48 hours
Elderly
No specific dose adjustment is required for elderly patients solely based on age. However, since renal function naturally declines with age, elderly patients should have their creatinine clearance assessed and the dose adjusted accordingly if renal impairment is present. Elderly patients may also be more susceptible to drug interactions, so careful medication review is essential before starting fluconazole.
Renal Impairment
Fluconazole is primarily eliminated by the kidneys, with approximately 80% of the dose excreted unchanged in urine. Dose adjustment is necessary in patients with renal impairment:
- Creatinine clearance >50 mL/min: No dose adjustment needed
- Creatinine clearance 11-50 mL/min (not on dialysis): Give 50% of the recommended dose, or the full dose every 48 hours
- Patients on regular hemodialysis: Give the full dose after each dialysis session, as fluconazole is significantly removed by dialysis
Missed Dose
If you are taking fluconazole as a multi-day course and miss a dose, take it as soon as you remember. However, if it is nearly time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one. If you are unsure, contact your pharmacist or doctor for advice.
Overdose
In cases of fluconazole overdose, symptoms may include hallucinations and paranoid behavior in addition to the usual side effects (nausea, vomiting, diarrhea). Treatment is supportive and symptomatic. Fluconazole is largely excreted in urine, and a 3-hour hemodialysis session decreases plasma levels by approximately 50%. There is no specific antidote for fluconazole overdose. In case of suspected overdose, contact your local poison control center or emergency department immediately.
What Are the Side Effects of Fluconazol Vitabalans?
The most common side effects of fluconazole include headache, nausea, abdominal pain, diarrhea, and skin rash. Most side effects are mild and transient. Rare but serious adverse effects include hepatotoxicity, severe skin reactions (Stevens-Johnson syndrome), and QT prolongation. Contact your healthcare provider if you experience any concerning symptoms.
Like all medicines, Fluconazol Vitabalans can cause side effects, although not everyone experiences them. The frequency and severity of side effects may depend on the dose used and the duration of treatment. Single-dose therapy (150 mg for vaginal candidiasis) is generally very well tolerated, while higher doses and prolonged courses carry a greater risk of adverse effects.
The following side effects have been reported with fluconazole use. They are categorized by frequency according to the European Medicines Agency (EMA) convention:
Common (may affect up to 1 in 10 people)
- Headache
- Nausea
- Abdominal pain
- Diarrhea
- Skin rash
- Vomiting
- Flatulence
- Elevated liver enzymes (ALT, AST)
Uncommon (may affect up to 1 in 100 people)
- Dizziness
- Taste disturbance (dysgeusia)
- Insomnia
- Drowsiness
- Seizures
- Pruritus (itching)
- Urticaria (hives)
- Increased sweating
- Dry mouth
- Dyspepsia (indigestion)
- Cholestasis (impaired bile flow)
- Jaundice
- Elevated bilirubin
- Fatigue
- Malaise
- Muscle pain (myalgia)
Rare (may affect up to 1 in 1,000 people)
- Hepatotoxicity (serious liver damage, including hepatic failure)
- Hepatic necrosis
- Stevens-Johnson syndrome (SJS)
- Toxic epidermal necrolysis (TEN)
- Exfoliative dermatitis
- Anaphylaxis (severe allergic reaction)
- Angioedema (swelling of face, lips, tongue)
- QT prolongation on ECG
- Torsades de pointes (life-threatening heart rhythm)
- Agranulocytosis (very low white blood cell count)
- Thrombocytopenia (low platelet count)
- Leukopenia (low white blood cells)
- Hypokalemia (low potassium)
- Hyperlipidemia (elevated blood lipids)
- Alopecia (hair loss)
- Adrenal insufficiency
Contact your healthcare provider immediately or go to the nearest emergency department if you experience: yellowing of the skin or eyes (jaundice), severe skin rash with blistering or peeling, difficulty breathing or swelling of the face/throat, irregular or rapid heartbeat, unexplained persistent nausea or vomiting, or dark-colored urine. These may be signs of serious adverse reactions requiring urgent medical evaluation.
If you experience any side effects not listed above, or if any side effect becomes severe or bothersome, please report it to your healthcare provider. You can also report suspected adverse reactions to your national pharmacovigilance authority (for example, the Yellow Card Scheme in the UK, MedWatch in the US, or the corresponding system in your country).
How Should You Store Fluconazol Vitabalans?
Store Fluconazol Vitabalans at room temperature below 25°C (77°F), in the original packaging to protect from moisture and light. Keep out of reach and sight of children. Do not use after the expiry date printed on the packaging.
Proper storage of medications is essential to maintain their efficacy and safety throughout the shelf life. Fluconazol Vitabalans tablets should be stored under the following conditions:
- Temperature: Store below 25°C (77°F). Do not freeze.
- Moisture: Keep in the original blister pack until ready to use, to protect from moisture.
- Light: Store in the original carton to protect from light.
- Children: Keep out of the reach and sight of children.
- Expiry date: Do not use Fluconazol Vitabalans after the expiry date (EXP) stated on the blister and carton. The expiry date refers to the last day of that month.
Do not dispose of medications via wastewater or household waste. Ask your pharmacist how to dispose of medicines you no longer need. Proper disposal helps protect the environment and reduces the risk of accidental exposure.
What Does Fluconazol Vitabalans Contain?
Each Fluconazol Vitabalans tablet contains 150 mg of fluconazole as the active substance, along with inactive excipients used in the tablet formulation including lactose monohydrate, maize starch, sodium lauryl sulfate, colloidal anhydrous silica, and magnesium stearate.
Understanding the full composition of a medicine is important, particularly for patients with known allergies or intolerances to specific excipients.
Active Substance
- Fluconazole 150 mg: A triazole antifungal agent with the molecular formula C13H12F2N6O and a molecular weight of 306.3 g/mol. It is a white to off-white crystalline powder that is freely soluble in water.
Excipients (Inactive Ingredients)
The following inactive ingredients are typically included in the tablet formulation. The exact excipient list may vary slightly between batches; refer to the patient information leaflet enclosed with your specific pack for the definitive list:
- Lactose monohydrate: Used as a diluent/filler. Patients with rare hereditary galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should not take this medicine.
- Maize starch: Used as a disintegrant to help the tablet break down in the digestive tract.
- Sodium lauryl sulfate: A surfactant that aids in drug dissolution and absorption.
- Colloidal anhydrous silica: Used as a flow agent in the manufacturing process.
- Magnesium stearate: A lubricant used to prevent the tablet from sticking to manufacturing equipment.
Fluconazol Vitabalans tablets contain lactose monohydrate. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
Frequently Asked Questions about Fluconazol Vitabalans
Fluconazol Vitabalans contains fluconazole 150 mg and is used to treat a range of fungal infections caused by Candida and other susceptible organisms. Its most common use is treating uncomplicated vaginal candidiasis (vaginal thrush) with a single oral dose. It is also used for oropharyngeal candidiasis (oral thrush), esophageal candidiasis, systemic candidiasis, cryptococcal meningitis, dermatophyte infections, and as prophylaxis against fungal infections in immunocompromised patients. Your doctor will prescribe it based on your specific condition and the type of fungal infection identified.
Fluconazole is rapidly absorbed after oral administration, reaching peak blood levels within 1-2 hours. For vaginal candidiasis treated with a single 150 mg dose, most patients begin to notice symptom improvement within 24-72 hours, with complete resolution typically within about 7 days. The drug has a long half-life of approximately 30 hours, which means it continues to work for several days after a single dose. For other types of fungal infections requiring longer treatment courses, clinical improvement is usually observed within the first week, though the full course should always be completed as prescribed.
It is best to avoid or limit alcohol consumption while taking fluconazole. Both substances are metabolized by the liver, and combining them may increase the risk of liver damage (hepatotoxicity). Alcohol can also worsen common side effects of fluconazole such as nausea, headache, and dizziness. While a single drink is unlikely to cause serious problems for most people taking a single dose, it is prudent to minimize alcohol intake, especially during longer courses of treatment. If you have any pre-existing liver conditions, you should strictly avoid alcohol during fluconazole therapy.
Fluconazole is generally contraindicated during pregnancy, particularly at high doses or with prolonged use, due to reports of birth defects. While a single 150 mg dose for vaginal thrush has not been conclusively linked to increased risk in large studies, topical antifungal agents (such as clotrimazole or miconazole) are preferred during pregnancy. Regarding breastfeeding, fluconazole is excreted in breast milk at levels similar to blood levels. A single 150 mg dose is generally considered compatible with breastfeeding by expert organizations, but prolonged or high-dose use should be discussed with your healthcare provider. Always consult your doctor before taking any medication during pregnancy or while breastfeeding.
If you are taking fluconazole as a multi-day course and miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Never take a double dose to compensate. Due to fluconazole's long half-life (approximately 30 hours), missing a single dose is less likely to significantly compromise treatment compared to drugs with shorter half-lives. However, completing the full prescribed course is important to ensure the fungal infection is fully eradicated and to minimize the risk of antifungal resistance developing.
Yes, although it is rare, fluconazole has been associated with serious liver damage (hepatotoxicity), including cases of hepatitis, cholestasis, and fulminant hepatic failure. The risk is generally higher with higher doses, longer treatment duration, and in patients with pre-existing liver disease or serious underlying medical conditions. For short courses and single-dose treatment, clinically significant liver damage is very uncommon. If you are on prolonged fluconazole therapy, your doctor may recommend periodic liver function tests. Stop taking fluconazole and seek medical attention immediately if you develop symptoms of liver damage: persistent nausea, vomiting, abdominal pain, unusual fatigue, loss of appetite, yellowing of the skin or eyes, or dark urine.
References
- World Health Organization. WHO Model List of Essential Medicines – 23rd list (2023). Geneva: WHO; 2023.
- European Medicines Agency. Fluconazole – Summary of Product Characteristics. EMA; 2024.
- U.S. Food and Drug Administration. Diflucan (fluconazole) – FDA Prescribing Information. FDA; 2024.
- Pappas PG, Kauffman CA, Andes DR, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases. 2016;62(4):e1-e50. doi:10.1093/cid/civ933
- Cornely OA, Bassetti M, Calandra T, et al. ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clinical Microbiology and Infection. 2012;18(Suppl 7):19-37. doi:10.1111/1469-0691.12039
- Molgaard-Nielsen D, Pasternak B, Hviid A. Use of oral fluconazole during pregnancy and the risk of birth defects. New England Journal of Medicine. 2013;369(9):830-839. doi:10.1056/NEJMoa1301066
- Brammer KW, Farrow PR, Faulkner JK. Pharmacokinetics and tissue penetration of fluconazole in humans. Reviews of Infectious Diseases. 1990;12(Suppl 3):S318-S326.
- British National Formulary (BNF). Fluconazole. National Institute for Health and Care Excellence (NICE); 2024.
- Perfect JR, Dismukes WE, Dromer F, et al. Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases. 2010;50(3):291-322. doi:10.1086/649858
- Sobel JD. Vulvovaginal candidosis. The Lancet. 2007;369(9577):1961-1971. doi:10.1016/S0140-6736(07)60917-9
Editorial Team
This article was written and reviewed by the iMedic Medical Editorial Team, consisting of licensed physicians specializing in clinical pharmacology, infectious disease, and internal medicine. Our team follows international medical guidelines (WHO, EMA, FDA, IDSA, ESCMID) and uses the GRADE evidence framework to ensure the highest quality of medical information.
iMedic Medical Editorial Team
Specialists in Clinical Pharmacology & Infectious Disease
iMedic Medical Review Board
Independent review according to international guidelines
Level 1A – Based on systematic reviews, meta-analyses, and randomized controlled trials
No commercial funding. No pharmaceutical company sponsorship. Independent editorial content.